Novostia is a privately held medical device company developing an innovative artificial heart valve, especially for young patients.
With the support of world leading surgeons, Novostia endeavors to improve the quality of life of millions of patients worldwide suffering from aortic and mitral valve disease, while reducing overall healthcare costs.
Novostia's patented technology results from years of R&D with world leaders in fluid mechanics, advanced biomaterials, high-precision Swiss manufacturing and prominent academic laboratories.
Novostia's artificial heart valve has been designed by Dr. Didier Lapeyre, French cardiovascular surgeon, and Philippe Perrier, co-designer of the Rafale Aircraft at Dassault Aviation.
CONNECT. COLLABORATE. INNOVATE.
Novostia is based in Epalinges, Lausanne area, in the heart of the innovative community of the Biopôle. Biopôle is home to over 2,400 people from the world’s most innovative life sciences companies and research groups, so you’ll be at the centre of a constant flow of ideas that cross boundaries, generations and disciplines – part of the spirit of collaboration that drives our whole community.